Manufacturing companies Cellares, Antheia among the week’s fundings: Venture Report

The biological manufacturing sector was a focus of venture fundings this week, with Cellares drawing a massive series D and Antheia topping off its series B.

BlackRock and Eclipse led the $257 million round for Cellares Corp., a South San Francisco-based CDMO specializing in cell therapies. The company says it will support clinical manufacturing by mid-2026, with commercial manufacturing to follow in 2027. It has established several biopharma partnerships, most notably with Bristol Myers Squibb Co. (NYSE:BMY) for CAR T therapies...